Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: The novel oncogenic factor TET3 combines with AHR to promote thyroid cancer lymphangiogenesis via the HIF-1α/VEGF signaling pathway

Fig. 4

TET3 and AHR promote lymphangiogenesis, migration and invasion of THCA cells. A.C. Vasculogenic effects assessed based on capillary-like tubule structure formation. B.D. Number of tubes in every field (*P < 0.05, **P < 0.01). E.G. Transwell invasion assays performed to assess the migration and invasion abilities of THCA cells. F.H. Cell numbers in every field (*P < 0.05, **P < 0.01)

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us